Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland

Life Sciences

Volumn 64, Issue 25, 1999, Pages 2351-2358

  Moriya, Hiroki ^a   Takagi, Yoko ^a   Nakanishi, Takahiro ^a   Hayashi, Masatoshi ^a   Tani, Tadato ^a   Hirotsu, Ichiro ^a  

^a Sumitomo Metal Industries   (Japan)

Author keywords

Heart; MAChR subtype; Selective antagonist; Sf9 insect cells; Submandibular gland

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ATROPINE; DARIFENACIN; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PIRENZEPINE; PROPIVERINE; RECEPTOR SUBTYPE; TIMEPIDIUM BROMIDE; TIQUIZIUM; UNCLASSIFIED DRUG; ZAMIFENACIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HEART; LEPIDOPTERA; LIGAND BINDING; MALE; NONHUMAN; RAT; RECEPTOR AFFINITY; SUBMANDIBULAR GLAND;

ANIMALS; BACULOVIRIDAE; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; DNA PRIMERS; HUMANS; KINETICS; MALE; MUSCARINIC ANTAGONISTS; MYOCARDIUM; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; RECOMBINANT PROTEINS; SPODOPTERA; SUBMANDIBULAR GLAND;

ANIMALIA; INSECTA; LEPIDOPTERA; UNIDENTIFIED BACULOVIRUS;

EID: 0033553589     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00188-5     Document Type: Article

References (42)

1. N.M. Nathanson, Annu. Rev. Neurosci. 10 195-236 (1987)
2. T. Kubo, K. Fukuda, A. Mikami, A. Maeda, H. Takahashi, M. Mishima, T. Haga, K. Haga, A. Ichikawa, N. Minamino, H. Matsuo, T. Hirose and S. Numa, Nature 323 411-416 (1986)
3. E. G. Peralta, A. Ashkenazi, J. W. Winslow, D. H. Smith, J. Ramachandran and D. J. Capon, EMBO J. 6 3923-3929 (1987)
4. T. Bonner, N. J. Buckley, A. C. Young and M.R. Brann, Science 237 527-532 (1987)
5. J. Wess, N. Blin, E. Mutschler and K. Blüml, Life Sci. 56 915-922 (1995)
6. E. C. Hulme, N. J. M. Birdsall and N. J. Buckley, Annu. Rev. Pharmacol. Toxicol. 30 633-673 (1990)
7. M. P. Caulfield, Pharmacol. Ther. 58 319-379 (1993)
8. A. Maeda, T. Kubo, M. Mishima and M. Numa, FEBS Lett. 239 339-342 (1988)
9. R. M. Eglen, H. Reddy, N. Watson and R. A. J. Challiss, Trends Pharmacol. Sci. 15 114-119 (1994)
10. R. Hammer, C. P. Berrie, N. J. M. Birdsall, A. S. V. Burgen and E. C. Hulme, Nature 283 90-92 (1980)
11. R. Hammer, E. Giraldo, G. B. Schiavi, E. Monferini and H. Ladinsky, Life Sci. 38 1653-1662 (1986)
12. G. Lambrecht, R. Feifel, U. Moser, M. Wagner-Roder, L. K. Choo, J. Camus, M. Tastenoy, M. Waelbroeck, C. Strohmann, R. Tacke, J. F. Rodrigues De Miranda, J. Chridtophe and E. Mutschler, Sci. Suppl. IV 61-64 (1989)
13. S. Lazareno, N. J. Buckley and F. F. Roberts, Mol. Pharmacol. 38 805-815 (1990)
14. S. J. Wall, R. P. Yasuda, F. Hory, S. Flagg, B. M. Martin, E. I. Ginns and B. B. Wolfe, Mol. Pharmacol. 39 643-649 (1991)
15. M. Li, R. P. Yasuda, S. T. Wall, A. Wellstein and B. B. Wolfe, Mol. Pharmacol. 40 28-35 (1991)
16. S. T. Wall, R. P. Yasuda, M. Li and B. B. Wolfe, Mol. Pharmacol. 40 783-789 (1991)
17. R. P. Yasuda, W. Ciesla, L. R. Flores, S. T. Wall, M. Li, S. A. Satkus, J. S. Weisstein, B.V. Spagnola and B. B. Wolfe, Mol. Pharmacol. 43 149-157 (1993)
18. K. Fukuda, T. Kubo, A. Maeda, I. Akiba, H. Bujo, J. Nakai, M. Mishima, H. Higashida, E. Neher, A. Marty and S. Numa, Trends Pharmacol. Sci. Suppl. IV 4-10 (1989)
19. N. J. Buckley, T. I. Bonner, C. M. Buckley and M. R. Bramm, Mol. Pharmacol. 35 469-467 (1989)
20. F. Dörje, J. Wess, G. Lambrecht, R. Tacke, E. Mutschler and M. R. Brann, J. Pharmacol. Exp. Ther. 256 727-733 (1991)
21. G. Z. Dong, K. Kameyama, A. Rinken and T. Haga, J. Pharmacol. Exp. Ther. 254 378-384 (1995)
22. T. Maniatis, E. F. Fritsch and J. Sambrook(1982) Molecular Cloning. Cold Spring Harber Laboratory, Cold Spring Harber, NY
23. G. L. Peterson, Methods of Enzymol. 91 95-119 (1983)
24. E. H. Rosenthal, Anal. Biochem. 20 525-532 (1967)
25. J. Cheng and W. H. Prusoff, Biochem. Pharmacol. 22 3099-3108 (1973)
26. T. I. Bonner, A. C. Young, M. R. Brann and N. J. Buckley, Neuron 1 403-410 (1988)
27. C. Schudt, C. Auriga, B. Kinder and N. J. M. Birdsall, Euro. J. Pharmacol. 145 87-90 (1988)
28. R. M. Wallis, Life Sci. 56 861-868 (1995)
29. A. Rinken, K. Kameyama, T. Haga and L. Engström, Biochem. Pharmacol. 48 1245-1251 (1994)
30. H. Nakata, K. Kameyama, K. Haga and T. Haga, Eur. J. Biochem. 220 29-36 (1994)
31. C. J. Van Koppen and N. M. Nathanson, J. Biol. Chem. 265 20887-20892 (1990)
32. K. Ohara, H. Uchiyama, K. Ohara, T. Haga and A. Ichiyama, Eur. J. Pharmacol. 189 341-364 (1990)
33. A. Rinken, J. Pharmacol. Exp. Ther. 272 8-14 (1995)
34. E. K. Pedder, P. Eveleigh, D. Poyner, E. C. Hulme and N. J. Birdsall, Br. J. Pharmacol. 103, 1561-1567 (1991)
35. N. R. Cutler and J. J. Stramek, CNS Drugs 3 467-481 (1995)
36. H. N. Doods, 20 157-164 (1995)
37. P. J. Barnes, Life Sci. 52 521-527 (1993)
38. J. Wess, Trends Pharmacol. Sci. 17 308-313 (1993)
39. S. Tucék, J. Proska and J. Jakubik, J. Neurochem. 612 S19 (1993)
40. J. Proska and S. Tucék, Mol. Pharmacol. 45 709-717 (1994)
41. F. Mitchelson, Pharmac. Ther. 37 357-423 (1988)
42. Y. S. Dai, I. S. Ambudkar, V. J. Horn, C. K. Yeh, E. E. Kousvelari, S. J. Wall, M. Li, R. P. Yasauda, B. B. Wolfe and B. J. Baum, Am. J. Physiol. 261 C1063-73(1991)